NCT06526728

Brief Summary

The goal of this study is to learn if Hyperbaric Oxygen Therapy is able to accelerate and improve muscle healing following an acute hamstring injury. The main questions it aims to answer are:

  1. 1.Does Hyperbaric Oxygen Therapy accelerates the time needed to return to play/-duty following hamstring injury.
  2. 2.Does Hyperbaric Oxygen Therapy decrease the amount of reinjuries within 1 year following Return to play/-duty? Besides these questions this study will clinically and radiologically evaluate the healing process over time as well as the occurrence of (serious) adverse events.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at below P25 for phase_3

Timeline
23mo left

Started Oct 2024

Typical duration for phase_3

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress46%
Oct 2024Mar 2028

First Submitted

Initial submission to the registry

July 18, 2024

Completed
12 days until next milestone

First Posted

Study publicly available on registry

July 30, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

October 30, 2024

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2027

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2028

Last Updated

November 20, 2024

Status Verified

November 1, 2024

Enrollment Period

2.8 years

First QC Date

July 18, 2024

Last Update Submit

November 18, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Time to return to full unrestricted play / time to return to full unrestricted duty.

    Number of days from initial injury until the athlete is cleard to resume full unrestricted training / Number of days from initial injury until soldier is cleared to resume full unrestricted (physical) duty activities.

    From date of inclusion until the date of progresion to return to full unrestricted play or -duty. Assessed to up to 1 year

Secondary Outcomes (4)

  • Re-injury registration

    2- and 12 months following injury

  • Clinical assessment

    Baseline, week 2 and at return to full restricted play/-duty (assessed up to 1 year following injury)

  • Radiologic assessment

    Baseline and week 2

  • Adverse events

    Baseline up until 1 week following last treatment session.

Study Arms (1)

Treatment Arm

EXPERIMENTAL

Participants will be subjected to seven once-daily sessions of hyperbaric oxygen therapy. Generic Name: Oxygen Dosage: 100% Frequency: Once-daily Duration per treatment session: 115-120 minutes

Drug: Hyperbaric oxygen

Interventions

Participants will be subjected to seven once-daily sessions of hyperbaric oxygen therapy. Each session will last 115-120 minutes whereby the chambre will be pressurized to 2.4 ATA during which participants will breathe 100% (pure) oxygen.

Treatment Arm

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The participant is male or female, of any ethnic origin
  • The participant is between 18 and 65 years old
  • The participant has a clinical diagnosis of an acute hamstring injury ≤7 days old, defined as:
  • Anamnestic acute injury
  • Anamnestic pain in the posterior thigh
  • Localized pain during palpation of hamstring muscle
  • Localized pain during passive straight leg raise
  • Increased pain during isometric contraction
  • The participant is able to start of HBOT treatment ≤7 days)

You may not qualify if:

  • The participant is not capable of doing an active exercise program.
  • The participant does not have the intention to full sporting activity or duty activities;
  • The cause of the hamstring injury is an extrinsic trauma on the posterior thigh;
  • The participant has a chronic hamstring injury \>2 months, defined as recurrent pain or tenderness of the hamstring;
  • The current injury is a re-injury ≤2months after RTP/RTD after acute ipsilateral hamstring injury;
  • Clinical suspicion of a complete proximal tendon avulsions;
  • Presence of other concurrent injuries inhibiting rehabilitation;
  • The participant is not able to give informed consent;
  • There are contra-indications for MRI: Pacemaker, pregnancy and claustrophobia
  • There are contra-indications for HBOT:
  • Smoking or quit smoking \<3 months prior to injury;
  • A previous spontaneous pneumothorax.
  • Implantation of ICD or PM not compatible with hyperbaric pressure
  • Current or recent (\<6 months) use of cytostatics
  • Unable to perform a Valsalva manoeuvre to pressurize the middle ear (pre-existent ear-nose-throat complaints or a current upper airway infection).
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Amsterdam UMC

Amsterdam, North Holland, 1105AZ, Netherlands

RECRUITING

MeSH Terms

Interventions

Hyperbaric Oxygenation

Intervention Hierarchy (Ancestors)

Oxygen Inhalation TherapyRespiratory TherapyTherapeutics

Central Study Contacts

Milo J.K. Mokkenstorm, MD MSc

CONTACT

Prof. Dr. J.L. Tol

CONTACT

Study Design

Study Type
interventional
Phase
phase 3
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: 50 study participants will be treated with seven once-daily sessions of hyperbaric oxygen therapy following hamstring injury.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor of Sports Medicine, Principal investigator

Study Record Dates

First Submitted

July 18, 2024

First Posted

July 30, 2024

Study Start

October 30, 2024

Primary Completion (Estimated)

September 1, 2027

Study Completion (Estimated)

March 1, 2028

Last Updated

November 20, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

IPD will not be made pubicly available but can be obtained upon request at the study's sponsor. For data reuse, a Data Sharing Agreement will be set up .

Locations